Revenue-Cycle, Risk-Adjustment, and Reimbursement Enforcement Intensify

Arintra's $25M Series B, with health-system participation including Yale New Haven Health and Endeavor Health, illustrates accelerating interest in agentic coding, denial, and DRG tools. Recent fraud-response guidance reinforces the need to distinguish government demands, preserve records, coordinate counsel, protect privilege, and manage overlapping investigative and operational risks; unsupported diagnoses, documentation, coding, delegated entities, vendors, and incentive design remain enterprise governance issues.